All Stories

  1. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency
  2. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression
  3. p130Cas Scaffolds the Signalosome To Direct Adaptor-Effector Cross Talk during Kaposi's Sarcoma-Associated Herpesvirus Trafficking in Human Microvascular Dermal Endothelial Cells
  4. CIB1 Synergizes with EphrinA2 to Regulate Kaposi's Sarcoma-Associated Herpesvirus Macropinocytic Entry in Human Microvascular Dermal Endothelial Cells
  5. Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration
  6. Kaposi's Sarcoma-Associated Herpesvirus Induces the ATM and H2AX DNA Damage Response Early during De Novo Infection of Primary Endothelial Cells, Which Play Roles in Latency Establishment
  7. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies
  8. EphrinA2 Regulates Clathrin Mediated KSHV Endocytosis in Fibroblast Cells by Coordinating Integrin-Associated Signaling and c-Cbl Directed Polyubiquitination
  9. Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells
  10. Herpes Simplex Virus 1 Infection Induces Activation and Subsequent Inhibition of the IFI16 and NLRP3 Inflammasomes
  11. Kaposi's Sarcoma-Associated Herpesvirus Latency in Endothelial and B Cells Activates Gamma Interferon-Inducible Protein 16-Mediated Inflammasomes
  12. Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein
  13. Kaposi’s Sarcoma Associated Herpesvirus Entry into Target Cells
  14. Herpesviruses and Cancer
  15. Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma
  16. IFI16 Acts as a Nuclear Pathogen Sensor to Induce the Inflammasome in Response to Kaposi Sarcoma-Associated Herpesvirus Infection
  17. Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi's Sarcoma-Associated Herpesvirus
  18. Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion
  19. Kaposi Sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: A potential positive feedback loop for sustained ORF50 gene expression
  20. KSHV Entry and Infection of Target Cells
  21. Gammaherpesviruses entry and early events during infection
  22. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells☆
  23. Integrin α3β1 (CD 49c/29) Is a Cellular Receptor for Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) Entry into the Target Cells
  24. Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions
  25. Human Herpesvirus 8 Envelope-Associated Glycoprotein B Interacts with Heparan Sulfate-like Moieties
  26. Human Herpesvirus 8 Interaction with Target Cells Involves Heparan Sulfate
  27. Induction of HHV-8 Lytic Cycle Replication by Inflammatory Cytokines Produced by HIV-1-Infected T Cells
  28. The restricted cellular host range of human herpesvirus 8
  29. Characterization of the human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) oncogene, Kaposin (ORF K12)
  30. Differential Viral Protein Expression in Kaposi's Sarcoma-Associated Herpesvirus-Infected Diseases
  31. Characterization and Rapid Quantification of Lytic Human Herpesvirus 8 Infection in Single Cells by Flow Cytometric Analysis.
  32. Comparison of Human Sera Reactivities in Immunoblots with Recombinant Human Herpesvirus (HHV)-8 Proteins Associated with the Latent (ORF73) and Lytic (ORFs 65, K8.1A, and K8.1B) Replicative Cycles and in Immunofluorescence Assays with HHV-8-Infected BC...
  33. Human Herpesvirus-8 ORF K8.1 Gene Encodes Immunogenic Glycoproteins Generated by Spliced Transcripts
  34. An overview of serology of IIIIV-8 (KSIIV).
  35. Reactivities of Human Sera with Human Herpesvirus-8-Infected BCBL-1 Cells and Identification of HHV-8-Specific Proteins and Glycoproteins and the Encoding cDNAs
  36. Identification and Characterization of Human Herpesvirus-8 Lytic Cycle-Associated ORF 59 Protein and the Encoding cDNA by Monoclonal Antibody
  37. Frequent Detection of Kaposi's Sarcoma—Associated Herpesvirus (Human Herpesvirus 8) DNA in Saliva of Human Immunodeficiency Virus‐Infected Men: Clinical and Immunologic Correlates
  38. Detection of Human Herpesvirus 8 DNA in Kaposi's Sarcoma Lesions and Peripheral Blood of Human Immunodeficiency Virus‐Positive Patients and Correlation with Serologic Measurements
  39. The Human Immunodeficiency Virus tat Gene Enhances Replication of Human Herpesvirus-6
  40. INTERACTIONS BETWEEN HHV-6 AND HIV: CHARACTERIZATION OF THE HHV-6 GENES INVOLVED IN HIV ACTIVATION
  41. trans-Activation of the HIV Promoter by a cDNA and Its Genomic Clones of Human Herpesvirus-6
  42. Identification and Characterization of Glycoprotein gH of Human Herpesvirus-6
  43. Antigenic and genetic differentiation of the two putative types of human herpes virus 6
  44. Antigenic relationships among human herpesvirus‐6 isolates
  45. Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody